1Cassandra Willyard. Researchers look for ‘sweet' method to diagnose cancer. Nat Med, 2007, 13: 1267.
2Kladney RD, Bulla GA, Guo L, et al. GP73, a novel golgilocalized protein upregulated by viral infection. Gene, 2000, 249 : 53-65.
3Kladney RD, Cui X, Bulla GA, et al. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology, 2002, 35 : 1431-1440.
4Marrero JA, Romano PR, Nikolaeva O, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol, 2005, 43: 1007-1012.
5Sterling RK, Jeffers L, Gordon F, et al. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.Am J Gastroenterol, 2007, 102(10) :2196-2205.
6Cheng HT, Chang YH, Chen YY,et al. AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein. J Chin Med Assoc, 2007, 70(8) :310-317.
7Leerapun A, Suravarapu SV,Bida JP, et al. The utility of Lens cullnaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol, 2007, 5 (3) :394-402.
8Hagiwara S, Kudo M, Kawasaki T, et al. Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol, 2006, 41 (12) : 1214-1219.
9Cart BI, Kar S, Wang M, et al. Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix. Cell Biol Int, 2007, 31 (9) :929-938.
10Fnjikawa T, Shiraha H, Ueda N, et al. Des- gamma- carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem, 2007, 282(12) :8741-8748.
3KLADNEY R D, BULI,A G A. GUO L, et al. GP73, a Hoxel Golgi- localized protein upregulaied 13)viral infection[J]!. Gene, 2000, 249(1/2) : 53 -65.
4BLOCK T M, COMUNAI,E M A, I,OWMAN M. et al, Is++ of Uar- geted glycoproteonlics to idenlify serum glycoptoteins thai corrclatc with liver cancer in woodt+hucks and humans[J]. Proc Natl Atoad Sci U S A, 2005, 102(3): 779-784.
5WEI S. DUNN T .A, ISAACS W B, et al.GOLPH2 and MYO6: putative prostate cancer markers Iocalized to the Golgi aplattus [J]. Prostate , 2008, 68( 13): 1387-1395.
6ZHANG F, GU Y, Li X, et al. Up - regutated Golgi phosphipro- rein 2( GO1,PH2 ) expression in lung adenoeareinoma /issue [ J ]. Clin Biochem, 2010, 43(12) : 983 -991.
7KATADA T, ISHICURO H, KIMI. RA M, et al. GP73 conlrihules to the sensitivity of cisplatin itl esophageal cancer[ J ]. Esophagus, 2009, 6(3) : 173 -176.
8FRITZSCHE F R, KRISTIANSEN G, RIENEII M O. el al. GOL- PH2 expression may serve as diagnostic marker in seminomas[J]. BMC Urol, 2010, I0: 4.
9HARDY E, CASTLLANOS SERRA L R. "Reverse-staining"of biomoleules in eletriophc, resis gels: analylical and microprepara- live applications[ J ]. Anal Bic, ehem. 2004, 328( 1 ) : 1 - 13.
10Polanski M,Anderson NL. A list of candidate cancer biomar- kers for targeted proteomics. Biomarker Insights, 2007,1 : 1- 48.
